TSH Biopharm Corporation Limited 8432.TWO Stock
TSH Biopharm Corporation Limited Price Chart
TSH Biopharm Corporation Limited 8432.TWO Financial and Trading Overview
| TSH Biopharm Corporation Limited stock price | 56.6 TWD |
| Previous Close | 44.75 TWD |
| Open | 45.2 TWD |
| Bid | 44.6 TWD x 0 |
| Ask | 44.7 TWD x 0 |
| Day's Range | 44.3 - 45.2 TWD |
| 52 Week Range | 39 - 51.9 TWD |
| Volume | 39.07K TWD |
| Avg. Volume | 40.67K TWD |
| Market Cap | 1.71B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 32.31884 |
| EPS (TTM) | 1.61 TWD |
| Forward Dividend & Yield | 1.6 (3.49%) |
| Ex-Dividend Date | June 15, 2023 |
| 1y Target Est | N/A |
8432.TWO Valuation Measures
| Enterprise Value | 1.32B TWD |
| Trailing P/E | 32.31884 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.7117126 |
| Price/Book (mrq) | 1.562938 |
| Enterprise Value/Revenue | 2.869 |
| Enterprise Value/EBITDA | 21.571 |
Trading Information
TSH Biopharm Corporation Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 7.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 51.9 TWD |
| 52 Week Low | 39 TWD |
| 50-Day Moving Average | 45.68 TWD |
| 200-Day Moving Average | 46.01 TWD |
8432.TWO Share Statistics
| Avg. Volume (3 month) | 40.67K TWD |
| Avg. Daily Volume (10-Days) | 55.5K TWD |
| Shares Outstanding | 38.4M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 64.94% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.6 |
| Trailing Annual Dividend Yield | 3.57% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 1.087 |
| Last Split Factor | 1.1:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 11.51% |
| Operating Margin (ttm) | 11.79% |
| Gross Margin | 60.00% |
| EBITDA Margin | 13.30% |
Management Effectiveness
| Return on Assets (ttm) | 2.92% |
| Return on Equity (ttm) | 4.86% |
Income Statement
| Revenue (ttm) | 461.39M TWD |
| Revenue Per Share (ttm) | 12.01 TWD |
| Quarterly Revenue Growth (yoy) | -2.50% |
| Gross Profit (ttm) | 279.87M TWD |
| EBITDA | 61.37M TWD |
| Net Income Avi to Common (ttm) | 53.15M TWD |
| Diluted EPS (ttm) | 1.38 |
| Quarterly Earnings Growth (yoy) | -45.00000000000000000000000000000000% |
Balance Sheet
| Total Cash (mrq) | 434.78M TWD |
| Total Cash Per Share (mrq) | 11.4 TWD |
| Total Debt (mrq) | 7.93M TWD |
| Total Debt/Equity (mrq) | 0.73 TWD |
| Current Ratio (mrq) | 13.1 |
| Book Value Per Share (mrq) | 28.536 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 63.63M TWD |
| Levered Free Cash Flow (ttm) | -248879872 TWD |
Profile of TSH Biopharm Corporation Limited
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 3-1, Park Street |
| ZIP | 11503 |
| Phone | 886 2 2655 8525 |
| Website | https://www.tshbiopharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 76 |
TSH Biopharm Corporation Limited develops and markets medicines for chronic diseases in Taiwan. It offers products for cardiovascular, central nervous, gastrointestinal, and others, as well as liquid-biopsy diagnosis. The company is headquartered in Taipei city, Taiwan. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.
Q&A For TSH Biopharm Corporation Limited Stock
What is a current 8432.TWO stock price?
TSH Biopharm Corporation Limited 8432.TWO stock price today per share is 56.6 TWD.
How to purchase TSH Biopharm Corporation Limited stock?
You can buy 8432.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TSH Biopharm Corporation Limited?
The stock symbol or ticker of TSH Biopharm Corporation Limited is 8432.TWO.
Which industry does the TSH Biopharm Corporation Limited company belong to?
The TSH Biopharm Corporation Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does TSH Biopharm Corporation Limited have in circulation?
The max supply of TSH Biopharm Corporation Limited shares is 38.4M.
What is TSH Biopharm Corporation Limited Price to Earnings Ratio (PE Ratio)?
TSH Biopharm Corporation Limited PE Ratio is 35.15527700 now.
What was TSH Biopharm Corporation Limited earnings per share over the trailing 12 months (TTM)?
TSH Biopharm Corporation Limited EPS is 1.61 TWD over the trailing 12 months.
Which sector does the TSH Biopharm Corporation Limited company belong to?
The TSH Biopharm Corporation Limited sector is Healthcare.